|
| Author | Year | Study type | No. of patients | Treatment group (A, B, C, D, and E) | Device used | Total complication rate (%) | Severe complication rate (%) |
|
| Suzuki et al. [10] | 2012 | PT | 4 | B | Gynemesh bone anchored sling | 62.0% | 0% |
| Suzuki et al. [10] | 2012 | PT | 4 | B | Prolenemesh bone anchored sling | 62.0% | 0% |
| Migliari et al. [11] | 2006 | PT | 49 | B | Polypropylene sling | 96.0% | 0% |
| Bauer et al. [31] | 2016 | PT | 115 | B | Advance XP sling | 6.0% | 3.5% |
| Bauer et al. [30] | 2010 | PT | 137 | B | Advance sling | 13, 9% | 2.2% |
| Migliari et al. [37] | 2003 | PT | 9 | B | Polypropylene sling | 55, 5% | 0% |
| Bauer et al. [12] | 2009 | PT | 124 | B | Advance sling | 12, 9% | 0, 8% |
| Ferro et al. [28] | 2016 | PT | 29 | B | VIRTUE transobturator sling | 58, 6% | 0% |
| Galiano et al. [27] | 2016 | PT | 52 | B | TOMS transobturator sling | 13, 5% | 0% |
| Leruth et al. [23] | 2012 | PT | 173 | B | TOMS transobturator sling | 25, 4% | 0% |
| Zaragoza et al. [22] | 2005 | PT | 4 | B | INVANCE sling | 0% | 0% |
| John et al. [21] | 2005 | PT | 16 | B | Porcine skin collagen + polypropylene sling | 25.0% | 0% |
| Collado et al. [15] | 2018 | PT | 94 | B | Advance + advance XP sling | 23.4% | 0% |
| Collado et al. [14] | 2009 | PT | 27 | B | Invance sling | 26.0% | 0% |
| Trigo Rocha et al. [36] | 2008 | PT | 40 | D | AMS 800 artificial sphincter | 10.0% | 0% |
| Correia Lima et al. [32] | 2018 | PT | 15 | D | BR—SL—AS—904 artificial sphincter | 0% | 0% |
| Lai et al. [24] | 2009 | PT | 129 | D | AMS 800 artificial sphincter | — | — |
| Trigo Rocha et al. [20] | 2006 | PT | 25 | E | ProACT | 17.3% | 0% |
| Bauer et al. [41] | 2011 | PT | 24 | B | Advance sling | 16.7% | 0% |
| Noordhof et al. [35] | 2017 | PT | 143 | E | PRO-ACT | 9.8% | 2.1% |
| Seweryn et al. [34] | 2012 | PT | 38 | C | ATOMS readjustable transobturator sling | 52, 6% | 0% |
| Kim et al. [33] | 2016 | PT | 64 | C | MRS readjustable sling | 9, 4% | 4, 7% |
| Renè Yiou et al. [25] | 2014 | PT | 20 | E | PRO-ACT | 10.0% | 0% |
| Renè Yiou et al. [29] | 2016 | PT | 40 | B | TOMS transobturator sling | 17, 5% | 0% |
| Hoda et al. [26] | 2012 | PT | 124 | C | ATMOS readjustable transobturator sling | 60, 5% | 4.0% |
| Hoda et al. [26] | 2012 | PT | 99 | C | ATMOS readjustable transobturator sling | 68, 7% | 4.0% |
| Martens et al. [19] | 2009 | PT | 29 | E | PRO-ACT | 68.0% | 44, 8% |
| Introini et al. [18] | 2012 | PT | 66 | C | Silimed periurethral constrictor adjustable sling | 4, 5% | 0% |
| Le Portz et al. [17] | 2016 | PT | 93 | B | Surgimesh M-SLING | 2, 1% | 0% |
| Dikranian et al. [16] | 2004 | PT | 20 | A | Porcine dermal Collagene | 5.0% | 5.0% |
| Dikranian et al. [16] | 2004 | PT | 16 | B | Silicone mesh sling | 12.0% | 0% |
| Gregori et al. [13] | 2008 | PT | 11 | E | ProAct | 0% | 0% |
| Cestari et al. [9] | 2017 | RT | 120 | B | Autologous sling (6 branches versus 2 branches) | 6.7% | 5.0% |
| Van Uhm et al. [38] | 2018 | PT | 10 | A | Opsys bulking agent (polyacrylate polyalcohol copolymer | 40.0% | 0% |
| Cestari et al. [39] | 2015 | PT | 60 | B | Autologous sling | 10.0% | 0% |
| Stephen J et al. [40] | 2005 | PT | 15 | B | Sling polyglactin mesh | 0% | 0% |
| Crivellaro et al. [21] | 2008 | PT | 46 | E | Pro-ACT | 12.3% | 4% |
| Crivellaro et al. [21] | 2008 | PT | 38 | B | BAMS polypropylene bulbourethral sling | 19.4% | 10.9% |
| Queissert F et al. [43] | 2022 | PT | 12 | C | ATMOS readjustable transobturator sling | — | — |
|
